Try GOLD - Free

How Digital Transformation Strategy could transform Indonesia's healthcare system for the better

BioSpectrum Asia

|

BioSpectrum Asia June 2023

Since the COVID-19 epidemic, the digital healthcare business in Indonesia has rapidly expanded. The country needed to modernise its healthcare system, including digitalisation, in addition to enhancing performance and accessibility. Concerns over Indonesia’s healthcare future led to investments in digital healthcare, and the government is now working to encourage its spread.

How Digital Transformation Strategy could transform Indonesia's healthcare system for the better

Indonesia’s healthcare sector plays a crucial role in safeguarding the well-being of its people and communities. However, with a population of over 270 million spread across thousands of islands, ensuring equitable access to healthcare services is a significant challenge.

Indonesia’s healthcare industry needs more healthcare talents. The issue is that there are more medical graduates than available job opportunities in the healthcare sector, even in cities. Hospitals then exploit this supply and demand disparity to hire doctors as cheaply as possible to maximise profits, making this more unattractive for local graduates.

Existing doctors work double-triple shifts in multiple places, which can also result in stress and burnout. Many also choose to fly abroad and find better-paying jobs outside the country, resulting in doctor shortage issues in second and thirdtier regions. This condition has an impact on the fulfilment of health talents to build this country’s health landscape to be on par with other developed countries and neighbouring countries in Southeast Asia (SEA).

According to the Ministry of Health of the Republic of Indonesia (MoH), the country requires over 160,000 doctors. At the same time, one of the healthcare reforms planned by the Minister, Budi Gunadi Sadikin, revolves around healthcare talent, among five others, in the 2020-2024 Digital Transformation Strategy. The strategy aims to transform the healthcare system into a more efficient, effective, patient-centred model.

In strengthening and improving healthcare talent, the MoH has also extensively supported health education through multiple scholarship programmes, which aim to support the equitable distribution of health workers. In the future, the government expects that all Indonesian provinces will have essential health services, such as heart disease treatments, by 2024.

MORE STORIES FROM BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

Waters launches charge detection mass spectrometry technology

US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterisation for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Chulalongkorn University launches Thailand's first master's programme in Nurse Anesthesia

The Faculty of Nursing, Chulalongkorn University, has officially launched the \"Master of Nursing Science Programme in Nurse Anesthesia\" - the first of its kind in Thailand.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

WHO strengthens coordination for NTD programmes and supply chain delivery

The World Health Organization (WHO), together with health ministries, pharmaceutical donours, implementing partners and technical support platforms, is strengthening coordination for neglected tropical disease (NTD) programmes and supply chain delivery, through three major back-to-back meetings in Geneva.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

All-in-one coronavirus vaccines to save millions in future pandemics

A new study reveals that vaccines designed to protect against a wide range of coronaviruses could dramatically reduce deaths and economic disruption and limit the need for lockdowns in the event of another global coronavirus pandemic.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

NTU in Singapore introduces Master of Science course in Chinese Medicine

From 2026, Nanyang Technological University (NTU) in Singapore will start offering a Master of Science in Chinese Medicine to develop highly skilled postgraduates with advanced expertise in both the theoretical foundations and practical applications of Chinese medicine.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

ProSpecBio launches Activin-A recombinant protein for brain injury research

Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell-derived recombinant Activin-A, now available for immediate delivery worldwide.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

PAHO publishes guide for designing AI instructions in public health

The Pan American Health Organization (PAHO) has launched a new guide providing practical advice on how to create Artificial Intelligence (AI) prompts that generate reliable, relevant, and culturally appropriate content across diverse contexts.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Prerna launches India's first MicroRNA based blood test for breast cancer screening

Precision RNA Biotech (Prerna), a healthcare startup from Hyderabad, India has announced the launch of Cantel, India's first microRNA-based blood test for breast cancer screening.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr

India-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan

Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy Subcutaneous Injection, a once-weekly subcutaneous injection formulation of GLP-1 receptor agonist indicated for the treatment of obesity disease.

time to read

1 min

BioSpectrum Asia Nov 2025

Translate

Share

-
+

Change font size